283 related articles for article (PubMed ID: 10980135)
1. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.
Bastian BC; LeBoit PE; Pinkel D
Am J Pathol; 2000 Sep; 157(3):967-72. PubMed ID: 10980135
[TBL] [Abstract][Full Text] [Related]
2. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Spectrum of Microscopic and Cytogenetic Findings Associated With Spitz Tumors With 11p Gains.
Lezcano CM; Yeh I; Eslamdoost N; Fang Y; LeBoit PE; McCalmont TH; Moy AP; Zhang Y; Busam KJ
Am J Surg Pathol; 2021 Feb; 45(2):277-285. PubMed ID: 33428338
[TBL] [Abstract][Full Text] [Related]
4. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.
Tetzlaff MT; Reuben A; Billings SD; Prieto VG; Curry JL
Clin Lab Med; 2017 Sep; 37(3):431-448. PubMed ID: 28802494
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway.
Maldonado JL; Timmerman L; Fridlyand J; Bastian BC
Am J Pathol; 2004 May; 164(5):1783-7. PubMed ID: 15111324
[TBL] [Abstract][Full Text] [Related]
6. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.
van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA
Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
Busam KJ; Kutzner H; Cerroni L; Wiesner T
Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
[TBL] [Abstract][Full Text] [Related]
8. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
9. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
10. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
11. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
Harvell JD; Bastian BC; LeBoit PE
Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
13. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.
Bastian BC; Wesselmann U; Pinkel D; Leboit PE
J Invest Dermatol; 1999 Dec; 113(6):1065-9. PubMed ID: 10594753
[TBL] [Abstract][Full Text] [Related]
15. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K
Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
[TBL] [Abstract][Full Text] [Related]
18. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
19. Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas.
Lazova R; Pornputtapong N; Halaban R; Bosenberg M; Bai Y; Chai H; Krauthammer M
Mod Pathol; 2017 May; 30(5):640-649. PubMed ID: 28186096
[TBL] [Abstract][Full Text] [Related]
20. Benign and Intermediate-grade Melanocytic Tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma.
Zhao J; Benton S; Zhang B; Olivares S; Asadbeigi S; Busam K; Gerami P
Am J Surg Pathol; 2022 Apr; 46(4):476-485. PubMed ID: 34753863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
